Back to Search
Start Over
Parvovirus B19‐associated graft failure after allogeneic hematopoietic stem cell transplantation
- Source :
- Cancer Reports, Vol 5, Iss 1, Pp n/a-n/a (2022), Cancer Reports
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
-
Abstract
- Background Parvovirus B19 (PVB19) infection has been implicated in allograft failure or dysfunction in solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo‐HSCT), but the literature is limited. Case Two pediatric patients were diagnosed with PVB19 infection around the time of allo‐HSCT graft failure. Both cases were secondary graft failure and required second allo‐HSCT. Conclusion There are many risk factors and potential confounders in determining the exact etiology of graft failure after allo‐HSCT. These two cases highlight the importance of including PVB19 in the diagnostic evaluation for graft failure. PVB19 infection may be an important risk factor for allo‐HSCT graft failure.
- Subjects :
- Graft Rejection
Male
Oncology
Cancer Research
medicine.medical_specialty
Graft failure
Adolescent
Allograft failure
medicine.medical_treatment
graft failure
Secondary Graft Failure
Case Report
chemical and pharmacologic phenomena
Hematopoietic stem cell transplantation
parvovirus B19 infection
Parvoviridae Infections
Risk Factors
immune system diseases
Internal medicine
hemic and lymphatic diseases
Parvovirus B19, Human
medicine
Humans
allogeneic hematopoietic stem cell transplantation
Risk factor
RC254-282
biology
Parvovirus
business.industry
Hematopoietic Stem Cell Transplantation
Infant
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
biology.organism_classification
surgical procedures, operative
Etiology
Solid organ transplantation
business
Subjects
Details
- Language :
- English
- ISSN :
- 25738348
- Volume :
- 5
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Cancer Reports
- Accession number :
- edsair.doi.dedup.....7d766ca94ce2acfe270683a916f63194